Emitents | Grindeks, AS (5299006DWR32NKWM1O86) |
Veids | Būtiski notikumi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2010-04-14 11:18:13 |
Versijas komentārs | |
Teksts |
JSC "Grindeks" informs that it has received Statement of "Grindeks" Vice-chairman of the Council Vitālijs Gavrilovs on his resignation from the position of the Member of Council.
On “Grindeks” “Grindeks” is the leading pharmaceutical company in the Baltic States. Its main fields of action are: research, development, manufacturing and sale of original products, generics and active pharmaceutical ingredients. “Grindeks” specializes in the heart and cardiovascular, CNS and anti-cancer medication therapeutic groups. Group consists of four subsidiary companies in Latvia, Estonia and Russia, as well representatives and representative offices in fourteen countries. Products of the company are exported to more than 40 countries and its export comprises more than 96% of the total turnover. The main markets are: the Baltic States, Russia and other CIS countries, Japan, USA. JSC “Grindeks” shares are listed in the Official List of “NASDAQ OMX Riga”.
Further information:
|
Pielikumi |
|